Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs1260326

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr2:27508073 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
T>C / T>G
Variation Type
SNV Single Nucleotide Variation
Frequency
T=0.413253 (148338/358952, ALFA)
T=0.325645 (86195/264690, TOPMED)
T=0.326470 (45696/139970, GnomAD) (+ 24 more)
T=0.357150 (43303/121246, ExAC)
T=0.27792 (21870/78692, PAGE_STUDY)
C=0.43453 (12279/28258, 14KJPN)
C=0.43771 (7336/16760, 8.3KJPN)
T=0.32408 (4215/13006, GO-ESP)
T=0.2870 (1838/6404, 1000G_30x)
T=0.2933 (1469/5008, 1000G)
T=0.3741 (1676/4480, Estonian)
T=0.4058 (1564/3854, ALSPAC)
T=0.3997 (1482/3708, TWINSUK)
C=0.4580 (1342/2930, KOREAN)
T=0.3399 (707/2080, HGDP_Stanford)
T=0.3152 (592/1878, HapMap)
T=0.3805 (414/1088, Daghestan)
T=0.360 (359/998, GoNL)
C=0.456 (359/788, PRJEB37584)
T=0.288 (173/600, NorthernSweden)
T=0.418 (223/534, MGP)
T=0.238 (114/478, SGDP_PRJ)
T=0.391 (119/304, FINRISK)
T=0.412 (89/216, Qatari)
T=0.26 (13/50, Siberian)
T=0.43 (18/42, Ancient Sardinia)
T=0.40 (16/40, GENOME_DK)
Clinical Significance
Reported in ClinVar
Gene : Consequence
GCKR : Missense Variant
Publications
220 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 375314 T=0.409271 C=0.590729
European Sub 314784 T=0.424227 C=0.575773
African Sub 16106 T=0.14858 C=0.85142
African Others Sub 592 T=0.103 C=0.897
African American Sub 15514 T=0.15032 C=0.84968
Asian Sub 6866 T=0.5216 C=0.4784
East Asian Sub 4902 T=0.5430 C=0.4570
Other Asian Sub 1964 T=0.4679 C=0.5321
Latin American 1 Sub 1488 T=0.3427 C=0.6573
Latin American 2 Sub 7218 T=0.3350 C=0.6650
South Asian Sub 5218 T=0.2547 C=0.7453
Other Sub 23634 T=0.41610 C=0.58390


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
Allele Frequency Aggregator Total Global 358952 T=0.413253 C=0.586747
Allele Frequency Aggregator European Sub 304704 T=0.424816 C=0.575184
Allele Frequency Aggregator Other Sub 22190 T=0.41965 C=0.58035
Allele Frequency Aggregator African Sub 11268 T=0.15486 C=0.84514
Allele Frequency Aggregator Latin American 2 Sub 7218 T=0.3350 C=0.6650
Allele Frequency Aggregator Asian Sub 6866 T=0.5216 C=0.4784
Allele Frequency Aggregator South Asian Sub 5218 T=0.2547 C=0.7453
Allele Frequency Aggregator Latin American 1 Sub 1488 T=0.3427 C=0.6573
TopMed Global Study-wide 264690 T=0.325645 C=0.674355
gnomAD - Genomes Global Study-wide 139970 T=0.326470 C=0.673530
gnomAD - Genomes European Sub 75822 T=0.40089 C=0.59911
gnomAD - Genomes African Sub 41954 T=0.14404 C=0.85596
gnomAD - Genomes American Sub 13614 T=0.37799 C=0.62201
gnomAD - Genomes Ashkenazi Jewish Sub 3318 T=0.5419 C=0.4581
gnomAD - Genomes East Asian Sub 3114 T=0.5016 C=0.4984
gnomAD - Genomes Other Sub 2148 T=0.3496 C=0.6504
ExAC Global Study-wide 121246 T=0.357150 C=0.642850
ExAC Europe Sub 73254 T=0.40488 C=0.59512
ExAC Asian Sub 25132 T=0.32679 C=0.67321
ExAC American Sub 11552 T=0.32142 C=0.67858
ExAC African Sub 10402 T=0.13536 C=0.86464
ExAC Other Sub 906 T=0.342 C=0.658
The PAGE Study Global Study-wide 78692 T=0.27792 C=0.72208
The PAGE Study AfricanAmerican Sub 32508 T=0.15006 C=0.84994
The PAGE Study Mexican Sub 10810 T=0.33913 C=0.66087
The PAGE Study Asian Sub 8318 T=0.5329 C=0.4671
The PAGE Study PuertoRican Sub 7918 T=0.2999 C=0.7001
The PAGE Study NativeHawaiian Sub 4532 T=0.3570 C=0.6430
The PAGE Study Cuban Sub 4230 T=0.4095 C=0.5905
The PAGE Study Dominican Sub 3828 T=0.2926 C=0.7074
The PAGE Study CentralAmerican Sub 2450 T=0.3180 C=0.6820
The PAGE Study SouthAmerican Sub 1982 T=0.3350 C=0.6650
The PAGE Study NativeAmerican Sub 1260 T=0.3198 C=0.6802
The PAGE Study SouthAsian Sub 856 T=0.236 C=0.764
14KJPN JAPANESE Study-wide 28258 T=0.56547 C=0.43453
8.3KJPN JAPANESE Study-wide 16760 T=0.56229 C=0.43771
GO Exome Sequencing Project Global Study-wide 13006 T=0.32408 C=0.67592
GO Exome Sequencing Project European American Sub 8600 T=0.4169 C=0.5831
GO Exome Sequencing Project African American Sub 4406 T=0.1430 C=0.8570
1000Genomes_30x Global Study-wide 6404 T=0.2870 C=0.7130
1000Genomes_30x African Sub 1786 T=0.0929 C=0.9071
1000Genomes_30x Europe Sub 1266 T=0.4139 C=0.5861
1000Genomes_30x South Asian Sub 1202 T=0.2022 C=0.7978
1000Genomes_30x East Asian Sub 1170 T=0.4812 C=0.5188
1000Genomes_30x American Sub 980 T=0.349 C=0.651
1000Genomes Global Study-wide 5008 T=0.2933 C=0.7067
1000Genomes African Sub 1322 T=0.0938 C=0.9062
1000Genomes East Asian Sub 1008 T=0.4812 C=0.5188
1000Genomes Europe Sub 1006 T=0.4105 C=0.5895
1000Genomes South Asian Sub 978 T=0.200 C=0.800
1000Genomes American Sub 694 T=0.362 C=0.638
Genetic variation in the Estonian population Estonian Study-wide 4480 T=0.3741 C=0.6259
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 T=0.4058 C=0.5942
UK 10K study - Twins TWIN COHORT Study-wide 3708 T=0.3997 C=0.6003
KOREAN population from KRGDB KOREAN Study-wide 2930 T=0.5420 C=0.4580, G=0.0000
HGDP-CEPH-db Supplement 1 Global Study-wide 2080 T=0.3399 C=0.6601
HGDP-CEPH-db Supplement 1 Est_Asia Sub 466 T=0.455 C=0.545
HGDP-CEPH-db Supplement 1 Central_South_Asia Sub 414 T=0.302 C=0.698
HGDP-CEPH-db Supplement 1 Middle_Est Sub 350 T=0.503 C=0.497
HGDP-CEPH-db Supplement 1 Europe Sub 320 T=0.434 C=0.566
HGDP-CEPH-db Supplement 1 Africa Sub 242 T=0.062 C=0.938
HGDP-CEPH-db Supplement 1 America Sub 216 T=0.176 C=0.824
HGDP-CEPH-db Supplement 1 Oceania Sub 72 T=0.03 C=0.97
HapMap Global Study-wide 1878 T=0.3152 C=0.6848
HapMap American Sub 766 T=0.347 C=0.653
HapMap African Sub 682 T=0.116 C=0.884
HapMap Asian Sub 254 T=0.606 C=0.394
HapMap Europe Sub 176 T=0.528 C=0.472
Genome-wide autozygosity in Daghestan Global Study-wide 1088 T=0.3805 C=0.6195
Genome-wide autozygosity in Daghestan Daghestan Sub 608 T=0.398 C=0.602
Genome-wide autozygosity in Daghestan Near_East Sub 144 T=0.431 C=0.569
Genome-wide autozygosity in Daghestan Central Asia Sub 122 T=0.361 C=0.639
Genome-wide autozygosity in Daghestan Europe Sub 106 T=0.368 C=0.632
Genome-wide autozygosity in Daghestan South Asian Sub 72 T=0.15 C=0.85
Genome-wide autozygosity in Daghestan Caucasus Sub 36 T=0.44 C=0.56
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 T=0.360 C=0.640
CNV burdens in cranial meningiomas Global Study-wide 788 T=0.544 C=0.456
CNV burdens in cranial meningiomas CRM Sub 788 T=0.544 C=0.456
Northern Sweden ACPOP Study-wide 600 T=0.288 C=0.712
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 T=0.418 C=0.582
SGDP_PRJ Global Study-wide 478 T=0.238 C=0.762
FINRISK Finnish from FINRISK project Study-wide 304 T=0.391 C=0.609
Qatari Global Study-wide 216 T=0.412 C=0.588
Siberian Global Study-wide 50 T=0.26 C=0.74
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 42 T=0.43 C=0.57
The Danish reference pan genome Danish Study-wide 40 T=0.40 C=0.60
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 2 NC_000002.12:g.27508073T>C
GRCh38.p14 chr 2 NC_000002.12:g.27508073T>G
GRCh37.p13 chr 2 NC_000002.11:g.27730940T>C
GRCh37.p13 chr 2 NC_000002.11:g.27730940T>G
GCKR RefSeqGene NG_028024.1:g.16235T>C
GCKR RefSeqGene NG_028024.1:g.16235T>G
Gene: GCKR, glucokinase regulator (plus strand)
Molecule type Change Amino acid[Codon] SO Term
GCKR transcript NM_001486.4:c.1337T>C L [CTG] > P [CCG] Coding Sequence Variant
glucokinase regulatory protein NP_001477.2:p.Leu446Pro L (Leu) > P (Pro) Missense Variant
GCKR transcript NM_001486.4:c.1337T>G L [CTG] > R [CGG] Coding Sequence Variant
glucokinase regulatory protein NP_001477.2:p.Leu446Arg L (Leu) > R (Arg) Missense Variant
GCKR transcript variant X4 XM_011532763.1:c. N/A Genic Downstream Transcript Variant
GCKR transcript variant X1 XM_017003796.2:c.767T>C L [CTG] > P [CCG] Coding Sequence Variant
glucokinase regulatory protein isoform X1 XP_016859285.1:p.Leu256Pro L (Leu) > P (Pro) Missense Variant
GCKR transcript variant X1 XM_017003796.2:c.767T>G L [CTG] > R [CGG] Coding Sequence Variant
glucokinase regulatory protein isoform X1 XP_016859285.1:p.Leu256Arg L (Leu) > R (Arg) Missense Variant
GCKR transcript variant X2 XM_017003797.2:c.767T>C L [CTG] > P [CCG] Coding Sequence Variant
glucokinase regulatory protein isoform X1 XP_016859286.1:p.Leu256Pro L (Leu) > P (Pro) Missense Variant
GCKR transcript variant X2 XM_017003797.2:c.767T>G L [CTG] > R [CGG] Coding Sequence Variant
glucokinase regulatory protein isoform X1 XP_016859286.1:p.Leu256Arg L (Leu) > R (Arg) Missense Variant
GCKR transcript variant X3 XR_001738699.1:n. N/A Genic Downstream Transcript Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: C (allele ID: 23790 )
ClinVar Accession Disease Names Clinical Significance
RCV000009294.2 Fasting plasma glucose level quantitative trait locus 5 Association
RCV001618209.6 not provided Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement T= C G
GRCh38.p14 chr 2 NC_000002.12:g.27508073= NC_000002.12:g.27508073T>C NC_000002.12:g.27508073T>G
GRCh37.p13 chr 2 NC_000002.11:g.27730940= NC_000002.11:g.27730940T>C NC_000002.11:g.27730940T>G
GCKR RefSeqGene NG_028024.1:g.16235= NG_028024.1:g.16235T>C NG_028024.1:g.16235T>G
GCKR transcript NM_001486.4:c.1337= NM_001486.4:c.1337T>C NM_001486.4:c.1337T>G
GCKR transcript NM_001486.3:c.1337= NM_001486.3:c.1337T>C NM_001486.3:c.1337T>G
GCKR transcript variant X1 XM_017003796.2:c.767= XM_017003796.2:c.767T>C XM_017003796.2:c.767T>G
GCKR transcript variant X1 XM_017003796.1:c.767= XM_017003796.1:c.767T>C XM_017003796.1:c.767T>G
GCKR transcript variant X2 XM_017003797.2:c.767= XM_017003797.2:c.767T>C XM_017003797.2:c.767T>G
GCKR transcript variant X2 XM_017003797.1:c.767= XM_017003797.1:c.767T>C XM_017003797.1:c.767T>G
glucokinase regulatory protein NP_001477.2:p.Leu446= NP_001477.2:p.Leu446Pro NP_001477.2:p.Leu446Arg
glucokinase regulatory protein isoform X1 XP_016859285.1:p.Leu256= XP_016859285.1:p.Leu256Pro XP_016859285.1:p.Leu256Arg
glucokinase regulatory protein isoform X1 XP_016859286.1:p.Leu256= XP_016859286.1:p.Leu256Pro XP_016859286.1:p.Leu256Arg
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

201 SubSNP, 29 Frequency, 2 ClinVar submissions
No Submitter Submission ID Date (Build)
1 KWOK ss1932517 Oct 18, 2000 (87)
2 SC_JCM ss2468242 Nov 08, 2000 (89)
3 YUSUKE ss3236651 Sep 28, 2001 (100)
4 WI_SSAHASNP ss11466788 Jul 11, 2003 (116)
5 EGP_SNPS ss12568673 Aug 26, 2003 (117)
6 WUGSC_SSAHASNP ss14499079 Dec 05, 2003 (119)
7 CSHL-HAPMAP ss16855742 Feb 27, 2004 (120)
8 PERLEGEN ss24292559 Sep 20, 2004 (123)
9 ABI ss44327089 Mar 13, 2006 (126)
10 IMCJ-GDT ss46563928 Mar 13, 2006 (126)
11 ILLUMINA ss65730634 Oct 13, 2006 (127)
12 ILLUMINA ss66637290 Nov 29, 2006 (127)
13 EGP_SNPS ss66860378 Nov 29, 2006 (127)
14 ILLUMINA ss67024271 Nov 29, 2006 (127)
15 ILLUMINA ss67346198 Nov 29, 2006 (127)
16 CSHL-HAPMAP ss68385447 Jan 12, 2007 (127)
17 ILLUMINA ss70413024 May 16, 2007 (127)
18 ILLUMINA ss70577089 May 24, 2008 (130)
19 ILLUMINA ss71118717 May 16, 2007 (127)
20 ILLUMINA ss75514433 Dec 06, 2007 (129)
21 SI_EXO ss76896911 Dec 06, 2007 (129)
22 HGSV ss78913005 Dec 06, 2007 (129)
23 KRIBB_YJKIM ss83708414 Dec 15, 2007 (130)
24 CORNELL ss86270068 Mar 23, 2008 (129)
25 BCMHGSC_JDW ss91096564 Mar 24, 2008 (129)
26 BGI ss106077047 Feb 04, 2009 (130)
27 1000GENOMES ss109344687 Jan 24, 2009 (130)
28 1000GENOMES ss109988645 Jan 24, 2009 (130)
29 ILLUMINA-UK ss117633177 Feb 14, 2009 (130)
30 ILLUMINA ss121584068 Dec 01, 2009 (131)
31 ENSEMBL ss138409896 Dec 01, 2009 (131)
32 ILLUMINA ss153244239 Dec 01, 2009 (131)
33 GMI ss156831921 Dec 01, 2009 (131)
34 ILLUMINA ss159226563 Dec 01, 2009 (131)
35 SEATTLESEQ ss159701659 Dec 01, 2009 (131)
36 ILLUMINA ss160286608 Dec 01, 2009 (131)
37 ENSEMBL ss161254921 Dec 01, 2009 (131)
38 COMPLETE_GENOMICS ss163221735 Jul 04, 2010 (132)
39 COMPLETE_GENOMICS ss164049782 Jul 04, 2010 (132)
40 COMPLETE_GENOMICS ss166319498 Jul 04, 2010 (132)
41 ILLUMINA ss170177969 Jul 04, 2010 (132)
42 ILLUMINA ss172179691 Jul 04, 2010 (132)
43 PAGE_STUDY ss181341918 Jul 04, 2010 (132)
44 PAGE_STUDY ss181835886 Jul 04, 2010 (132)
45 BUSHMAN ss200192809 Jul 04, 2010 (132)
46 BCM-HGSC-SUB ss205797760 Jul 04, 2010 (132)
47 1000GENOMES ss219134011 Jul 14, 2010 (132)
48 1000GENOMES ss231086312 Jul 14, 2010 (132)
49 1000GENOMES ss238660093 Jul 15, 2010 (132)
50 ILLUMINA ss244276968 Jul 04, 2010 (132)
51 BL ss252989606 May 09, 2011 (134)
52 GMI ss276394977 May 04, 2012 (137)
53 GMI ss284312637 Apr 25, 2013 (138)
54 PJP ss292532129 May 09, 2011 (134)
55 NHLBI-ESP ss342051875 May 09, 2011 (134)
56 ILLUMINA ss410838570 Sep 17, 2011 (135)
57 ILLUMINA ss410900962 Sep 17, 2011 (135)
58 PAGE_STUDY ss469414642 May 04, 2012 (137)
59 ILLUMINA ss479783518 May 04, 2012 (137)
60 ILLUMINA ss479789983 May 04, 2012 (137)
61 ILLUMINA ss480363222 Sep 08, 2015 (146)
62 ILLUMINA ss484690174 May 04, 2012 (137)
63 1000GENOMES ss489808833 May 04, 2012 (137)
64 EXOME_CHIP ss491316760 May 04, 2012 (137)
65 CLINSEQ_SNP ss491780659 May 04, 2012 (137)
66 ILLUMINA ss536799144 Sep 08, 2015 (146)
67 NCBI-CURATED-RECORDS ss537713215 Jan 04, 2013 (137)
68 TISHKOFF ss555433082 Apr 25, 2013 (138)
69 SSMP ss649013419 Apr 25, 2013 (138)
70 ILLUMINA ss778786328 Aug 21, 2014 (142)
71 ILLUMINA ss780774062 Aug 21, 2014 (142)
72 ILLUMINA ss782791873 Aug 21, 2014 (142)
73 ILLUMINA ss783453884 Aug 21, 2014 (142)
74 ILLUMINA ss783757564 Aug 21, 2014 (142)
75 ILLUMINA ss825382298 Apr 01, 2015 (144)
76 ILLUMINA ss832044645 Apr 01, 2015 (144)
77 ILLUMINA ss832738928 Aug 21, 2014 (142)
78 ILLUMINA ss833329758 Aug 21, 2014 (142)
79 ILLUMINA ss834246327 Aug 21, 2014 (142)
80 JMKIDD_LAB ss974441568 Aug 21, 2014 (142)
81 EVA-GONL ss976615197 Aug 21, 2014 (142)
82 JMKIDD_LAB ss1067435927 Aug 21, 2014 (142)
83 JMKIDD_LAB ss1068952935 Aug 21, 2014 (142)
84 1000GENOMES ss1296398597 Aug 21, 2014 (142)
85 HAMMER_LAB ss1397285915 Sep 08, 2015 (146)
86 DDI ss1428514612 Apr 01, 2015 (144)
87 EVA_GENOME_DK ss1578790741 Apr 01, 2015 (144)
88 EVA_FINRISK ss1584017614 Apr 01, 2015 (144)
89 EVA_DECODE ss1586019868 Apr 01, 2015 (144)
90 EVA_UK10K_ALSPAC ss1603069414 Apr 01, 2015 (144)
91 EVA_UK10K_TWINSUK ss1646063447 Apr 01, 2015 (144)
92 EVA_EXAC ss1686236623 Apr 01, 2015 (144)
93 EVA_MGP ss1710957684 Apr 01, 2015 (144)
94 EVA_SVP ss1712440202 Apr 01, 2015 (144)
95 ILLUMINA ss1752350621 Sep 08, 2015 (146)
96 ILLUMINA ss1752350622 Sep 08, 2015 (146)
97 HAMMER_LAB ss1796455007 Sep 08, 2015 (146)
98 ILLUMINA ss1917747314 Feb 12, 2016 (147)
99 WEILL_CORNELL_DGM ss1919847411 Feb 12, 2016 (147)
100 ILLUMINA ss1946035447 Feb 12, 2016 (147)
101 ILLUMINA ss1958400197 Feb 12, 2016 (147)
102 GENOMED ss1968721998 Jul 19, 2016 (147)
103 JJLAB ss2020452164 Sep 14, 2016 (149)
104 ILLUMINA ss2094805766 Dec 20, 2016 (150)
105 ILLUMINA ss2095088866 Dec 20, 2016 (150)
106 USC_VALOUEV ss2148496664 Dec 20, 2016 (150)
107 HUMAN_LONGEVITY ss2228532673 Dec 20, 2016 (150)
108 SYSTEMSBIOZJU ss2624741546 Nov 08, 2017 (151)
109 ILLUMINA ss2633587591 Nov 08, 2017 (151)
110 ILLUMINA ss2633587592 Nov 08, 2017 (151)
111 ILLUMINA ss2633587593 Nov 08, 2017 (151)
112 ILLUMINA ss2635087329 Nov 08, 2017 (151)
113 GRF ss2703057710 Nov 08, 2017 (151)
114 GNOMAD ss2732555293 Nov 08, 2017 (151)
115 GNOMAD ss2746647471 Nov 08, 2017 (151)
116 GNOMAD ss2771106718 Nov 08, 2017 (151)
117 AFFY ss2985162602 Nov 08, 2017 (151)
118 AFFY ss2985786859 Nov 08, 2017 (151)
119 SWEGEN ss2989173652 Nov 08, 2017 (151)
120 EVA_SAMSUNG_MC ss3023058027 Nov 08, 2017 (151)
121 BIOINF_KMB_FNS_UNIBA ss3023992397 Nov 08, 2017 (151)
122 CSHL ss3344130407 Nov 08, 2017 (151)
123 ILLUMINA ss3628018928 Oct 11, 2018 (152)
124 ILLUMINA ss3628018929 Oct 11, 2018 (152)
125 ILLUMINA ss3631556097 Oct 11, 2018 (152)
126 ILLUMINA ss3633192941 Oct 11, 2018 (152)
127 ILLUMINA ss3633904277 Oct 11, 2018 (152)
128 ILLUMINA ss3634756897 Oct 11, 2018 (152)
129 ILLUMINA ss3634756898 Oct 11, 2018 (152)
130 ILLUMINA ss3635590721 Oct 11, 2018 (152)
131 ILLUMINA ss3636442741 Oct 11, 2018 (152)
132 ILLUMINA ss3637342551 Oct 11, 2018 (152)
133 ILLUMINA ss3638248935 Oct 11, 2018 (152)
134 ILLUMINA ss3639129166 Oct 11, 2018 (152)
135 ILLUMINA ss3639576037 Oct 11, 2018 (152)
136 ILLUMINA ss3640464201 Oct 11, 2018 (152)
137 ILLUMINA ss3640464202 Oct 11, 2018 (152)
138 ILLUMINA ss3641102994 Oct 11, 2018 (152)
139 ILLUMINA ss3641398755 Oct 11, 2018 (152)
140 ILLUMINA ss3643219914 Oct 11, 2018 (152)
141 ILLUMINA ss3644738144 Oct 11, 2018 (152)
142 OMUKHERJEE_ADBS ss3646259363 Oct 11, 2018 (152)
143 ILLUMINA ss3652381906 Oct 11, 2018 (152)
144 ILLUMINA ss3653933329 Oct 11, 2018 (152)
145 EGCUT_WGS ss3657128246 Jul 13, 2019 (153)
146 EVA_DECODE ss3703490572 Jul 13, 2019 (153)
147 ACPOP ss3728257308 Jul 13, 2019 (153)
148 ILLUMINA ss3744473059 Jul 13, 2019 (153)
149 ILLUMINA ss3745056848 Jul 13, 2019 (153)
150 ILLUMINA ss3745056849 Jul 13, 2019 (153)
151 EVA ss3756504519 Jul 13, 2019 (153)
152 PAGE_CC ss3770905135 Jul 13, 2019 (153)
153 ILLUMINA ss3772553727 Jul 13, 2019 (153)
154 ILLUMINA ss3772553728 Jul 13, 2019 (153)
155 KHV_HUMAN_GENOMES ss3800885076 Jul 13, 2019 (153)
156 EVA ss3823754408 Apr 25, 2020 (154)
157 EVA ss3825519358 Apr 25, 2020 (154)
158 EVA ss3825536220 Apr 25, 2020 (154)
159 EVA ss3825596977 Apr 25, 2020 (154)
160 EVA ss3826880711 Apr 25, 2020 (154)
161 EVA ss3836847579 Apr 25, 2020 (154)
162 EVA ss3842262174 Apr 25, 2020 (154)
163 HGDP ss3847610596 Apr 25, 2020 (154)
164 SGDP_PRJ ss3851844688 Apr 25, 2020 (154)
165 KRGDB ss3897258298 Apr 25, 2020 (154)
166 FSA-LAB ss3984171609 Apr 26, 2021 (155)
167 FSA-LAB ss3984171610 Apr 26, 2021 (155)
168 EVA ss3984479371 Apr 26, 2021 (155)
169 EVA ss3984880684 Apr 26, 2021 (155)
170 EVA ss3986017075 Apr 26, 2021 (155)
171 EVA ss3986174825 Apr 26, 2021 (155)
172 EVA ss4016985813 Apr 26, 2021 (155)
173 TOPMED ss4498395060 Apr 26, 2021 (155)
174 TOMMO_GENOMICS ss5150422010 Apr 26, 2021 (155)
175 EVA ss5236969183 Apr 26, 2021 (155)
176 EVA ss5237168641 Apr 26, 2021 (155)
177 EVA ss5237635362 Oct 17, 2022 (156)
178 1000G_HIGH_COVERAGE ss5247340340 Oct 17, 2022 (156)
179 TRAN_CS_UWATERLOO ss5314400698 Oct 17, 2022 (156)
180 EVA ss5314719247 Oct 17, 2022 (156)
181 EVA ss5327598422 Oct 17, 2022 (156)
182 HUGCELL_USP ss5447609609 Oct 17, 2022 (156)
183 EVA ss5506333030 Oct 17, 2022 (156)
184 1000G_HIGH_COVERAGE ss5522181031 Oct 17, 2022 (156)
185 EVA ss5623920062 Oct 17, 2022 (156)
186 EVA ss5624097813 Oct 17, 2022 (156)
187 SANFORD_IMAGENETICS ss5624439762 Oct 17, 2022 (156)
188 SANFORD_IMAGENETICS ss5628333892 Oct 17, 2022 (156)
189 TOMMO_GENOMICS ss5678774443 Oct 17, 2022 (156)
190 EVA ss5799525651 Oct 17, 2022 (156)
191 EVA ss5800048341 Oct 17, 2022 (156)
192 EVA ss5800093379 Oct 17, 2022 (156)
193 YY_MCH ss5802029376 Oct 17, 2022 (156)
194 EVA ss5819820236 Oct 17, 2022 (156)
195 EVA ss5847860695 Oct 17, 2022 (156)
196 EVA ss5848510410 Oct 17, 2022 (156)
197 EVA ss5852439842 Oct 17, 2022 (156)
198 EVA ss5929521781 Oct 17, 2022 (156)
199 EVA ss5936515403 Oct 17, 2022 (156)
200 EVA ss5954536070 Oct 17, 2022 (156)
201 EVA ss5981203702 Oct 17, 2022 (156)
202 1000Genomes NC_000002.11 - 27730940 Oct 11, 2018 (152)
203 1000Genomes_30x NC_000002.12 - 27508073 Oct 17, 2022 (156)
204 The Avon Longitudinal Study of Parents and Children NC_000002.11 - 27730940 Oct 11, 2018 (152)
205 Genome-wide autozygosity in Daghestan NC_000002.10 - 27584444 Apr 25, 2020 (154)
206 Genetic variation in the Estonian population NC_000002.11 - 27730940 Oct 11, 2018 (152)
207 ExAC NC_000002.11 - 27730940 Oct 11, 2018 (152)
208 FINRISK NC_000002.11 - 27730940 Apr 25, 2020 (154)
209 The Danish reference pan genome NC_000002.11 - 27730940 Apr 25, 2020 (154)
210 gnomAD - Genomes NC_000002.12 - 27508073 Apr 26, 2021 (155)
211 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 1598661 (NC_000002.11:27730939:T:T 92157/251160, NC_000002.11:27730939:T:C 159003/251160)
Row 1598662 (NC_000002.11:27730939:T:T 251159/251160, NC_000002.11:27730939:T:G 1/251160)

- Jul 13, 2019 (153)
212 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 1598661 (NC_000002.11:27730939:T:T 92157/251160, NC_000002.11:27730939:T:C 159003/251160)
Row 1598662 (NC_000002.11:27730939:T:T 251159/251160, NC_000002.11:27730939:T:G 1/251160)

- Jul 13, 2019 (153)
213 GO Exome Sequencing Project NC_000002.11 - 27730940 Oct 11, 2018 (152)
214 Genome of the Netherlands Release 5 NC_000002.11 - 27730940 Apr 25, 2020 (154)
215 HGDP-CEPH-db Supplement 1 NC_000002.10 - 27584444 Apr 25, 2020 (154)
216 HapMap NC_000002.12 - 27508073 Apr 25, 2020 (154)
217 KOREAN population from KRGDB NC_000002.11 - 27730940 Apr 25, 2020 (154)
218 Medical Genome Project healthy controls from Spanish population NC_000002.11 - 27730940 Apr 25, 2020 (154)
219 Northern Sweden NC_000002.11 - 27730940 Jul 13, 2019 (153)
220 The PAGE Study NC_000002.12 - 27508073 Jul 13, 2019 (153)
221 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000002.11 - 27730940 Apr 26, 2021 (155)
222 CNV burdens in cranial meningiomas NC_000002.11 - 27730940 Apr 26, 2021 (155)
223 Qatari NC_000002.11 - 27730940 Apr 25, 2020 (154)
224 SGDP_PRJ NC_000002.11 - 27730940 Apr 25, 2020 (154)
225 Siberian NC_000002.11 - 27730940 Apr 25, 2020 (154)
226 8.3KJPN NC_000002.11 - 27730940 Apr 26, 2021 (155)
227 14KJPN NC_000002.12 - 27508073 Oct 17, 2022 (156)
228 TopMed NC_000002.12 - 27508073 Apr 26, 2021 (155)
229 UK 10K study - Twins NC_000002.11 - 27730940 Oct 11, 2018 (152)
230 ALFA NC_000002.12 - 27508073 Apr 26, 2021 (155)
231 ClinVar RCV000009294.2 Oct 11, 2018 (152)
232 ClinVar RCV001618209.6 Oct 17, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17705011 Oct 08, 2004 (123)
rs58226775 May 24, 2008 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss78913005, ss3639129166, ss3639576037 NC_000002.9:27642590:T:C NC_000002.12:27508072:T:C (self)
236091, 288488, ss91096564, ss109344687, ss109988645, ss117633177, ss160286608, ss163221735, ss164049782, ss166319498, ss200192809, ss205797760, ss244276968, ss252989606, ss276394977, ss284312637, ss292532129, ss410900962, ss479783518, ss491780659, ss825382298, ss1397285915, ss1586019868, ss1712440202, ss2635087329, ss3643219914, ss3847610596 NC_000002.10:27584443:T:C NC_000002.12:27508072:T:C (self)
7317036, 4061509, 2866494, 6101203, 14075, 4966774, 212888, 1784411, 4435692, 74436, 1542173, 106611, 28697, 1889341, 3861668, 1013018, 8391317, 4061509, ss219134011, ss231086312, ss238660093, ss342051875, ss479789983, ss480363222, ss484690174, ss489808833, ss491316760, ss536799144, ss555433082, ss649013419, ss778786328, ss780774062, ss782791873, ss783453884, ss783757564, ss832044645, ss832738928, ss833329758, ss834246327, ss974441568, ss976615197, ss1067435927, ss1068952935, ss1296398597, ss1428514612, ss1578790741, ss1584017614, ss1603069414, ss1646063447, ss1686236623, ss1710957684, ss1752350621, ss1752350622, ss1796455007, ss1917747314, ss1919847411, ss1946035447, ss1958400197, ss1968721998, ss2020452164, ss2094805766, ss2095088866, ss2148496664, ss2624741546, ss2633587591, ss2633587592, ss2633587593, ss2703057710, ss2732555293, ss2746647471, ss2771106718, ss2985162602, ss2985786859, ss2989173652, ss3023058027, ss3344130407, ss3628018928, ss3628018929, ss3631556097, ss3633192941, ss3633904277, ss3634756897, ss3634756898, ss3635590721, ss3636442741, ss3637342551, ss3638248935, ss3640464201, ss3640464202, ss3641102994, ss3641398755, ss3644738144, ss3646259363, ss3652381906, ss3653933329, ss3657128246, ss3728257308, ss3744473059, ss3745056848, ss3745056849, ss3756504519, ss3772553727, ss3772553728, ss3823754408, ss3825519358, ss3825536220, ss3825596977, ss3826880711, ss3836847579, ss3851844688, ss3897258298, ss3984171609, ss3984171610, ss3984479371, ss3984880684, ss3986017075, ss3986174825, ss4016985813, ss5150422010, ss5314719247, ss5327598422, ss5506333030, ss5623920062, ss5624097813, ss5624439762, ss5628333892, ss5799525651, ss5800048341, ss5800093379, ss5819820236, ss5847860695, ss5848510410, ss5936515403, ss5954536070, ss5981203702 NC_000002.11:27730939:T:C NC_000002.12:27508072:T:C (self)
RCV000009294.2, RCV001618209.6, 9706966, 51992979, 1758633, 126604, 12611547, 302217939, 1299590210, ss537713215, ss2228532673, ss3023992397, ss3703490572, ss3770905135, ss3800885076, ss3842262174, ss4498395060, ss5236969183, ss5237168641, ss5237635362, ss5247340340, ss5314400698, ss5447609609, ss5522181031, ss5678774443, ss5802029376, ss5852439842, ss5929521781 NC_000002.12:27508072:T:C NC_000002.12:27508072:T:C (self)
ss11466788 NT_022184.12:6546872:T:C NC_000002.12:27508072:T:C (self)
ss14499079, ss16855742 NT_022184.13:6546872:T:C NC_000002.12:27508072:T:C (self)
ss76896911 NT_022184.14:6546872:T:C NC_000002.12:27508072:T:C (self)
ss1932517, ss2468242, ss3236651, ss12568673, ss24292559, ss44327089, ss46563928, ss65730634, ss66637290, ss66860378, ss67024271, ss67346198, ss68385447, ss70413024, ss70577089, ss71118717, ss75514433, ss83708414, ss86270068, ss106077047, ss121584068, ss138409896, ss153244239, ss156831921, ss159226563, ss159701659, ss161254921, ss170177969, ss172179691, ss181341918, ss181835886, ss410838570, ss469414642 NT_022184.15:6552826:T:C NC_000002.12:27508072:T:C (self)
4435692, ss3897258298 NC_000002.11:27730939:T:G NC_000002.12:27508072:T:G (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

220 citations for rs1260326
PMID Title Author Year Journal
18439548 Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Ridker PM et al. 2008 American journal of human genetics
18439552 Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Reiner AP et al. 2008 American journal of human genetics
18556336 The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population. Vaxillaire M et al. 2008 Diabetes
18678614 Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations. Orho-Melander M et al. 2008 Diabetes
18853134 The search for putative unifying genetic factors for components of the metabolic syndrome. Sjögren M et al. 2008 Diabetologia
19060906 Common variants at 30 loci contribute to polygenic dyslipidemia. Kathiresan S et al. 2009 Nature genetics
19060910 Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Sabatti C et al. 2009 Nature genetics
19073768 Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents. Tam CH et al. 2009 Diabetes
19148283 Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study. Deo RC et al. 2009 PLoS genetics
19299407 Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample. Lanktree MB et al. 2009 Journal of lipid research
19474294 Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Hindorff LA et al. 2009 Proceedings of the National Academy of Sciences of the United States of America
19526250 Glucokinase regulatory protein gene polymorphism affects postprandial lipemic response in a dietary intervention study. Shen H et al. 2009 Human genetics
19533084 Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk. Reiling E et al. 2009 Diabetologia
19643913 The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Beer NL et al. 2009 Human molecular genetics
19651812 Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Chambers JC et al. 2009 Diabetes
19656773 A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hegele RA et al. 2009 Human molecular genetics
19729614 Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Musunuru K et al. 2009 Arteriosclerosis, thrombosis, and vascular biology
19802338 Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Chasman DI et al. 2008 Circulation. Cardiovascular genetics
19847674 Functional variants of glucokinase regulatory protein and apolipoprotein A5 genes in ischemic stroke. Járomi L et al. 2010 Journal of molecular neuroscience
19913121 Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Talmud PJ et al. 2009 American journal of human genetics
20031591 Association of blood lipids with common DNA sequence variants at 19 genetic loci in the multiethnic United States National Health and Nutrition Examination Survey III. Keebler ME et al. 2009 Circulation. Cardiovascular genetics
20037589 A genome-wide perspective of genetic variation in human metabolism. Illig T et al. 2010 Nature genetics
20081857 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Saxena R et al. 2010 Nature genetics
20081858 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Dupuis J et al. 2010 Nature genetics
20160193 Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples. Weissglas-Volkov D et al. 2010 Circulation. Cardiovascular genetics
20231535 Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Smith NL et al. 2010 Circulation
20339536 Genome-wide association of lipid-lowering response to statins in combined study populations. Barber MJ et al. 2010 PloS one
20352598 Glucokinase-activating GCKR polymorphisms increase plasma levels of triglycerides and free fatty acids, but do not elevate cardiovascular risk in the Ludwigshafen Risk and Cardiovascular Health Study. Kozian DH et al. 2010 Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
20383146 New loci associated with kidney function and chronic kidney disease. Köttgen A et al. 2010 Nature genetics
20570915 Genetic determinants of major blood lipids in Pakistanis compared with Europeans. Saleheen D et al. 2010 Circulation. Cardiovascular genetics
20570916 Fine-mapping in African Americans of 8 recently discovered genetic loci for plasma lipids: the Jackson Heart Study. Keebler ME et al. 2010 Circulation. Cardiovascular genetics
20628598 Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects. Tam CH et al. 2010 PloS one
20657596 Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Johansen CT et al. 2010 Nature genetics
20661421 Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study. Bi M et al. 2010 PloS one
20802025 Genome-wide association study identifies novel loci for plasma levels of protein C: the ARIC study. Tang W et al. 2010 Blood
20820957 The genetics of insulin resistance: Where's Waldo? Watanabe RM et al. 2010 Current diabetes reports
20831840 Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned. Maasz A et al. 2010 Genome medicine
20839009 Association of common DNA sequence variants at 33 genetic loci with blood lipids in individuals of African ancestry from Jamaica. Gupta R et al. 2010 Human genetics
20839289 Impact of repeated measures and sample selection on genome-wide association studies of fasting glucose. Rasmussen-Torvik LJ et al. 2010 Genetic epidemiology
20844574 An immune response network associated with blood lipid levels. Inouye M et al. 2010 PLoS genetics
20886378 Physiologic characterization of type 2 diabetes-related loci. Grarup N et al. 2010 Current diabetes reports
21041806 Genetic determinants of plasma triglycerides. Johansen CT et al. 2011 Journal of lipid research
21054877 Inflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994. Ned RM et al. 2010 BMC medical genetics
21071687 TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population. Varbo A et al. 2011 Arteriosclerosis, thrombosis, and vascular biology
21091714 The genetics of type 2 diabetes: what have we learned from GWAS? Billings LK et al. 2010 Annals of the New York Academy of Sciences
21114848 GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? Mohás M et al. 2010 Cardiovascular diabetology
21282362 Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. De Silva NM et al. 2011 Diabetes
21300955 Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Dehghan A et al. 2011 Circulation
21386085 A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Kraja AT et al. 2011 Diabetes
21411509 Variants of GCKR affect both β-cell and kidney function in patients with newly diagnosed type 2 diabetes: the Verona newly diagnosed type 2 diabetes study 2. Bonetti S et al. 2011 Diabetes care
21421807 Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men. Stančáková A et al. 2011 Diabetes
21423719 Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. Speliotes EK et al. 2011 PLoS genetics
21441441 Associations of common genetic variants with age-related changes in fasting and postload glucose: evidence from 18 years of follow-up of the Whitehall II cohort. Jensen AC et al. 2011 Diabetes
21466885 Evaluation of the gene-age interactions in HDL cholesterol, LDL cholesterol, and triglyceride levels: the impact of the SORT1 polymorphism on LDL cholesterol levels is age dependent. Shirts BH et al. 2011 Atherosclerosis
21467728 Profile of participants and genotype distributions of 108 polymorphisms in a cross-sectional study of associations of genotypes with lifestyle and clinical factors: a project in the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study. Wakai K et al. 2011 Journal of epidemiology
21527746 Triglycerides and heart disease: still a hypothesis? Goldberg IJ et al. 2011 Arteriosclerosis, thrombosis, and vascular biology
21569451 Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study. Ling Y et al. 2011 BMC medical genetics
21597005 An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia. Johansen CT et al. 2011 Arteriosclerosis, thrombosis, and vascular biology
21602305 A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Greenawalt DM et al. 2011 Genome research
21647738 Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Wu Y et al. 2012 Inflammation
21674002 Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome. Perez-Martinez P et al. 2011 PloS one
21676895 A gene-centric association scan for Coagulation Factor VII levels in European and African Americans: the Candidate Gene Association Resource (CARe) Consortium. Taylor KC et al. 2011 Human molecular genetics
21738485 Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. Dumitrescu L et al. 2011 PLoS genetics
21768215 Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Tin A et al. 2011 Human molecular genetics
21789219 Effects of genetic variants in ADCY5, GIPR, GCKR and VPS13C on early impairment of glucose and insulin metabolism in children. Windholz J et al. 2011 PloS one
21848424 Genetic associations with metabolic syndrome and its quantitative traits by race/ethnicity in the United States. Vassy JL et al. 2011 Metabolic syndrome and related disorders
21860704 Implications of discoveries from genome-wide association studies in current cardiovascular practice. Jeemon P et al. 2011 World journal of cardiology
21862451 GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors. Benyamin B et al. 2011 Human molecular genetics
21868769 World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 3. Bloomgarden ZT et al. 2011 Diabetes care
21931561 Genetic association for renal traits among participants of African ancestry reveals new loci for renal function. Liu CT et al. 2011 PLoS genetics
21937998 Single-nucleotide polymorphisms at five loci are associated with C-reactive protein levels in a cohort of Filipino young adults. Curocichin G et al. 2011 Journal of human genetics
21949744 Effects of 16 genetic variants on fasting glucose and type 2 diabetes in South Asians: ADCY5 and GLIS3 variants may predispose to type 2 diabetes. Rees SD et al. 2011 PloS one
21976109 Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Delahanty RJ et al. 2011 American journal of epidemiology
21980298 Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. Böger CA et al. 2011 PLoS genetics
22001757 Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Chambers JC et al. 2011 Nature genetics
22022282 A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. Avery CL et al. 2011 PLoS genetics
22095588 Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Bechmann LP et al. 2012 Hepatology (Baltimore, Md.)
22105854 Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Santoro N et al. 2012 Hepatology (Baltimore, Md.)
22139419 New gene functions in megakaryopoiesis and platelet formation. Gieger C et al. 2011 Nature
22307069 Association of type 2 diabetes susceptibility loci with one-year weight loss in the look AHEAD clinical trial. Peter I et al. 2012 Obesity (Silver Spring, Md.)
22425169 Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol. Shirts BH et al. 2012 Atherosclerosis
22517333 Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study. Hishida A et al. 2012 Endocrine journal
22546499 Genome-wide association studies with metabolomics. Adamski J et al. 2012 Genome medicine
22558069 Association of common variants in TNFRSF13B, TNFSF13, and ANXA3 with serum levels of non-albumin protein and immunoglobulin isotypes in Japanese. Osman W et al. 2012 PloS one
22567092 MultiPhen: joint model of multiple phenotypes can increase discovery in GWAS. O'Reilly PF et al. 2012 PloS one
22629316 Multi-ethnic analysis of lipid-associated loci: the NHLBI CARe project. Musunuru K et al. 2012 PloS one
23028791 Multiple loci associated with renal function in African Americans. Shriner D et al. 2012 PloS one
23092954 SHAVE: shrinkage estimator measured for multiple visits increases power in GWAS of quantitative traits. Meirelles OD et al. 2013 European journal of human genetics
23150898 Evaluation of seven common lipid associated loci in a large Indian sib pair study. Rafiq S et al. 2012 Lipids in health and disease
23236364 Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. Elbers CC et al. 2012 PloS one
23275357 The association between hepatic fat content and liver injury in obese children and adolescents: effects of ethnicity, insulin resistance, and common gene variants. Santoro N et al. 2013 Diabetes care
23586973 Investigation of known estimated glomerular filtration rate loci in patients with type 2 diabetes. Deshmukh HA et al. 2013 Diabetic medicine
23800943 Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene. Tan HL et al. 2014 Journal of gastroenterology
23832694 Common genetic variants associated with lipid profiles in a Chinese pediatric population. Shen Y et al. 2013 Human genetics
24068962 Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. O'Seaghdha CM et al. 2013 PLoS genetics
24178511 Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip. Gaunt TR et al. 2013 Thrombosis and haemostasis
24274136 Biobanking across the phenome - at the center of chronic disease research. Imboden M et al. 2013 BMC public health
24535998 GCK, GCKR polymorphisms and risk of chronic kidney disease in Japanese individuals: data from the J-MICC Study. Hishida A et al. 2014 Journal of nephrology
24829591 Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming". Manti S et al. 2014 Hepatitis monthly
24830394 Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. Giambartolomei C et al. 2014 PLoS genetics
24843659 Insights into the genetic basis of type 2 diabetes. Kato N et al. 2013 Journal of diabetes investigation
24879641 Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families. Rees MG et al. 2014 Human molecular genetics
24918535 Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes. Tracz A et al. 2014 Experimental and clinical endocrinology & diabetes
24922540 Genetic determinants of long-term changes in blood lipid concentrations: 10-year follow-up of the GLACIER study. Varga TV et al. 2014 PLoS genetics
24931982 GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database. Leslie R et al. 2014 Bioinformatics (Oxford, England)
24932782 Genetic risk score and adiposity interact to influence triglyceride levels in a cohort of Filipino women. Zubair N et al. 2014 Nutrition & diabetes
24966605 Pediatric fatty liver disease: role of ethnicity and genetics. Marzuillo P et al. 2014 World journal of gastroenterology
25024592 Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis. Lim JW et al. 2014 World journal of gastroenterology
25176936 Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia. De Castro-Orós I et al. 2014 Circulation. Cardiovascular genetics
25238615 A gene variant in CERS2 is associated with rate of increase in albuminuria in patients with diabetes from ONTARGET and TRANSCEND. Shiffman D et al. 2014 PloS one
25430627 A genetic risk tool for obesity predisposition assessment and personalized nutrition implementation based on macronutrient intake. Goni L et al. 2015 Genes & nutrition
25573592 Functional variants of lipid level modifier MLXIPL, GCKR, GALNT2, CILP2, ANGPTL3 and TRIB1 genes in healthy Roma and Hungarian populations. Sumegi K et al. 2015 Pathology oncology research
25646370 Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. Matsuo H et al. 2016 Annals of the rheumatic diseases
25788527 Uric Acid and Cardiovascular Events: A Mendelian Randomization Study. Kleber ME et al. 2015 Journal of the American Society of Nephrology
25920552 Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array. Rodriguez S et al. 2016 European journal of human genetics
25976242 GCKR polymorphism influences liver fat content in patients with type 2 diabetes. Petit JM et al. 2016 Acta diabetologica
26043229 Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene. Santoro N et al. 2015 The Journal of clinical endocrinology and metabolism
26136510 The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents. Rousseaux J et al. 2015 Journal of lipid research
26174136 Three missense variants of metabolic syndrome-related genes are associated with alpha-1 antitrypsin levels. Setoh K et al. 2015 Nature communications
26291577 The dietary monounsaturated to saturated fatty acid ratio modulates the genetic effects of GCKR on serum lipid levels in children. Lee HJ et al. 2015 Clinica chimica acta; international journal of clinical chemistry
26374098 CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation. Wang L et al. 2015 Genome biology
26379859 Polymorphisms in the GCKR are associated with serum lipid traits, the risk of coronary artery disease and ischemic stroke. Zhou YJ et al. 2015 International journal of clinical and experimental medicine
26433129 GCKR and PPP1R3B identified as genome-wide significant loci for plasma lactate: the Atherosclerosis Risk in Communities (ARIC) study. Tin A et al. 2016 Diabetic medicine
26457389 Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study. Goffredo M et al. 2016 Hepatology (Baltimore, Md.)
26780889 Meta-analysis of lipid-traits in Hispanics identifies novel loci, population-specific effects, and tissue-specific enrichment of eQTLs. Below JE et al. 2016 Scientific reports
26833098 Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Kilpeläinen TO et al. 2016 Nature communications
26902266 Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes. Giri AK et al. 2016 Scientific reports
27094239 Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Joshi AD et al. 2016 Gastroenterology
27177774 Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population. Wu S et al. 2016 Lipids in health and disease
27181629 Identification of rs671, a common variant of ALDH2, as a gout susceptibility locus. Sakiyama M et al. 2016 Scientific reports
27286809 Bivariate genome-wide association study identifies novel pleiotropic loci for lipids and inflammation. Ligthart S et al. 2016 BMC genomics
27312935 Genetics of Insulin Resistance and the Metabolic Syndrome. Brown AE et al. 2016 Current cardiology reports
27327646 Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. Prins BP et al. 2016 PLoS medicine
27338949 Mendelian Randomisation study of the influence of eGFR on coronary heart disease. Charoen P et al. 2016 Scientific reports
27432166 Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial. Pastor-Villaescusa B et al. 2016 Trials
27532011 Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population. Wang X et al. 2016 Frontiers in genetics
27534721 Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis. López-Mejías R et al. 2016 Scientific reports
27657051 Molecular Pathogenesis of NASH. Caligiuri A et al. 2016 International journal of molecular sciences
27660121 A Common Gene Variant in Glucokinase Regulatory Protein Interacts With Glucose Metabolism on Diabetic Dyslipidemia: the Combined CODAM and Hoorn Studies. Simons N et al. 2016 Diabetes care
27782183 Evaluating the transferability of 15 European-derived fasting plasma glucose SNPs in Mexican children and adolescents. Langlois C et al. 2016 Scientific reports
27845333 Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study. Kwok MK et al. 2016 Scientific reports
27917368 Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health Study. Christensen CH et al. 2016 Frontiers in oncology
28133617 Molecular Analysis of a Genetic Variants Panel Related to Nutrients and Metabolism: Association with Susceptibility to Gestational Diabetes and Cardiometabolic Risk in Affected Women. Franzago M et al. 2017 Journal of diabetes research
28262806 Functional annotation of sixty-five type-2 diabetes risk SNPs and its application in risk prediction. Wu Y et al. 2017 Scientific reports
28298293 Discovery and fine-mapping of loci associated with MUFAs through trans-ethnic meta-analysis in Chinese and European populations. Hu Y et al. 2017 Journal of lipid research
28385800 An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels. Cheung CYY et al. 2017 Diabetes
28577571 Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review. Paththinige CS et al. 2017 Lipids in health and disease
28666712 The association between six genetic variants and blood lipid levels in pregnant Chinese Han women. Nie M et al. 2017 Journal of clinical lipidology
28679452 Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout. Rasheed H et al. 2017 Arthritis research & therapy
28695325 A modified response of NAFLD patients with non-significant fibrosis in nutritional counseling according to GCKR rs1260326. Kaliora AC et al. 2018 European journal of nutrition
28793914 Performance of gout definitions for genetic epidemiological studies: analysis of UK Biobank. Cadzow M et al. 2017 Arthritis research & therapy
28964830 Causal effects of cardiovascular risk factors on onset of major age-related diseases: A time-to-event Mendelian randomization study. He L et al. 2018 Experimental gerontology
29264510 Genetics of Sex Hormone-Binding Globulin and Testosterone Levels in Fertile and Infertile Men of Reproductive Age. Grigorova M et al. 2017 Journal of the Endocrine Society
29303622 Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers. Kamble PG et al. 2017 Upsala journal of medical sciences
29325775 Nutrigenetic variants and cardio-metabolic risk in women with or without gestational diabetes. Franzago M et al. 2018 Diabetes research and clinical practice
29385134 Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. Kawaguchi T et al. 2018 PloS one
29487372 Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy. Di Costanzo A et al. 2018 Scientific reports
29493856 Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease. Grove JI et al. 2018 Liver international
29648650 NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Sliz E et al. 2018 Human molecular genetics
29665034 Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort. Tricò D et al. 2018 Hepatology (Baltimore, Md.)
29855200 Common gene variants interactions related to uric acid transport are associated with knee osteoarthritis susceptibility. Fernández-Torres J et al. 2019 Connective tissue research
29976226 Mediation analysis to understand genetic relationships between habitual coffee intake and gout. Hutton J et al. 2018 Arthritis research & therapy
30074174 Meta-analysis of GABRB3 Gene Polymorphisms and Susceptibility to Autism Spectrum Disorder. Noroozi R et al. 2018 Journal of molecular neuroscience
30091126 Association of type 2 diabetes susceptible genes GCKR, SLC30A8, and FTO polymorphisms with gestational diabetes mellitus risk: a meta-analysis. Lin Z et al. 2018 Endocrine
30123371 Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout. Zhu W et al. 2018 The open rheumatology journal
30176313 Gene variants in AKT1, GCKR and SOCS3 are differentially associated with metabolic traits in Mexican Amerindians and Mestizos. Cid-Soto MA et al. 2018 Gene
30352097 Association of common gene variants in glucokinase regulatory protein with cardiorenal disease: A systematic review and meta-analysis. Simons PIHG et al. 2018 PloS one
30409984 Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomics. John SE et al. 2018 Scientific reports
30444569 Genetic determinants of steatosis and fibrosis progression in paediatric non-alcoholic fatty liver disease. Hudert CA et al. 2019 Liver international
30476131 Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. Wang X et al. 2019 International journal of epidemiology
30527264 Genotype effects of glucokinase regulator on lipid profiles and glycemic status are modified by circulating calcium levels: results from the Korean Genome and Epidemiology Study. Kim OY et al. 2018 Nutrition research (New York, N.Y.)
30626429 Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank. Narang RK et al. 2019 Arthritis research & therapy
30646922 Genetic polymorphisms associated with nonalcoholic fatty liver disease in Uyghur population: a case-control study and meta-analysis. Cai W et al. 2019 Lipids in health and disease
30924303 Gout and the risk of Alzheimer's disease: A Mendelian randomization study. Lee YH et al. 2019 International journal of rheumatic diseases
31134135 Pleiotropic Meta-Analysis of Age-Related Phenotypes Addressing Evolutionary Uncertainty in Their Molecular Mechanisms. Kulminski AM et al. 2019 Frontiers in genetics
31231424 Genetic and Epigenetic Studies in Diabetic Kidney Disease. Gu HF et al. 2019 Frontiers in genetics
31255630 Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. Zusi C et al. 2019 Digestive and liver disease
31270413
31505904 Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese Children. Di Costanzo A et al. 2019 International journal of molecular sciences
31578044 Maternal seafood consumption during pregnancy and child attention outcomes: a cohort study with gene effect modification by PUFA-related genes. Julvez J et al. 2020 International journal of epidemiology
31648709 Genome-Wide Assessment for Resting Heart Rate and Shared Genetics With Cardiometabolic Traits and Type 2 Diabetes. Guo Y et al. 2019 Journal of the American College of Cardiology
31666285 Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood. Olafsson S et al. 2020 Cancer epidemiology, biomarkers & prevention
31766143 Candidate Gene and Genome-Wide Association Studies for Circulating Leptin Levels Reveal Population and Sex-Specific Associations in High Cardiovascular Risk Mediterranean Subjects. Ortega-Azorín C et al. 2019 Nutrients
31796261 Contribution of genetic, biochemical and environmental factors on insulin resistance and obesity in Mexican young adults. Flores-Viveros KL et al. 2019 Obesity research & clinical practice
31884074 Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N et al. 2020 Gastroenterology
31910446 Genome-wide association study of metabolic syndrome in Korean populations. Oh SW et al. 2020 PloS one
31915598 Association of GCKR Gene Polymorphisms with the Risk of Nonalcoholic Fatty Liver Disease and Coronary Artery Disease in a Chinese Northern Han Population. Gao H et al. 2019 Journal of clinical and translational hepatology
31960587 The endothelial function biomarker soluble E-selectin is associated with nonalcoholic fatty liver disease. Simons N et al. 2020 Liver international
31998841 Functional validity, role, and implications of heavy alcohol consumption genetic loci. Thompson A et al. 2020 Science advances
32195538 Single Nucleotide Polymorphisms Related to Lipoprotein Metabolism Are Associated with Blood Lipid Changes following Regular Avocado Intake in a Randomized Control Trial among Adults with Overweight and Obesity. Hannon BA et al. 2020 The Journal of nutrition
32292418 Serum Uric Acid Level and Multiple Sclerosis: A Mendelian Randomization Study. Niu PP et al. 2020 Frontiers in genetics
32349377 Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients. Enomoto H et al. 2020 International journal of molecular sciences
32443539 Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan. Raja AM et al. 2020 International journal of molecular sciences
32556615 Metabolomic and genetic associations with insulin resistance in pregnancy. Liu Y et al. 2020 Diabetologia
32917775 Genetic Studies of Leptin Concentrations Implicate Leptin in the Regulation of Early Adiposity. Yaghootkar H et al. 2020 Diabetes
33105679 Genetic Variants Associated with Non-Alcoholic Fatty Liver Disease Do Not Associate with Measures of Sub-Clinical Atherosclerosis: Results from the IMPROVE Study. Castaldo L et al. 2020 Genes
33243135 Contribution of Rs780094 and Rs1260326 Polymorphisms in GCKR Gene to Non-alcoholic Fatty Liver Disease: A Meta-Analysis Involving 26,552 Participants. Li J et al. 2021 Endocrine, metabolic & immune disorders drug targets
33387670 The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants. Liu Z et al. 2022 Clinical gastroenterology and hepatology
33602293 GCKR common functional polymorphisms are associated with metabolic syndrome and its components: a 10-year retrospective cohort study in Iranian adults. Zahedi AS et al. 2021 Diabetology & metabolic syndrome
33810064 The Epidemiology and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Population Genetics Secondary Database Analysis. Butler F et al. 2021 Journal of personalized medicine
34025845 Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study. Mazidi M et al. 2021 Archives of medical science
34068824 Alcohol Consumption Is Associated with Poor Prognosis in Obese Patients with COVID-19: A Mendelian Randomization Study Using UK Biobank. Fan X et al. 2021 Nutrients
34427645 Lifestyle Factors and Genetic Variants on 2 Biological Age Measures: Evidence From 94 443 Taiwan Biobank Participants. Lin WY et al. 2022 The journals of gerontology. Series A, Biological sciences and medical sciences
34535014 Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease. Martin PJ et al. 2021 Blood advances
34594363 Suggestive Evidence for Causal Effect of Leptin Levels on Risk for Anorexia Nervosa: Results of a Mendelian Randomization Study. Peters T et al. 2021 Frontiers in genetics
35124268 Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19. Li J et al. 2022 Clinical gastroenterology and hepatology
35178663 Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. Chahal D et al. 2022 Hepatology international
35276241 Association of glucokinase gene and glucokinase regulatory protein gene polymorphisms with gestational diabetes mellitus: A case-control study. She L et al. 2022 Gene
35328045 Pleiotropic Effects of Common and Rare GCKR Exonic Mutations on Cardiometabolic Traits. Yeh KH et al. 2022 Genes
35333773 The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han population. Yuan F et al. 2022 Aging
35350411 "GENYAL" Study to Childhood Obesity Prevention: Methodology and Preliminary Results. Marcos-Pasero H et al. 2022 Frontiers in nutrition
35351696 Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss. Aldubayan MA et al. 2022 BMJ open
35365700 Association between glucokinase regulator gene polymorphisms and serum uric acid levels in Taiwanese adolescents. Ho LJ et al. 2022 Scientific reports
35620859 Contribution of a genetic risk score to ethnic differences in fatty liver disease. Kubiliun MJ et al. 2022 Liver international
35633389 Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case-control study using data from the UK Biobank. Sandoval-Plata G et al. 2022 Rheumatology international
35657990 Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes. Chen G et al. 2022 PloS one
35728485 Investigation of metabolomic biomarkers for childhood executive function and the role of genetic and dietary factors: The GUSTO cohort. Huang J et al. 2022 EBioMedicine
35881683 Genetic variants associated with metabolic dysfunction-associated fatty liver disease in western China. Liao S et al. 2022 Journal of clinical laboratory analysis
35999016 Study of common hypertriglyceridaemia genetic variants and subclinical atherosclerosis in a group of women with SLE and a control group. Fanlo-Maresma M et al. 2022 Lupus science & medicine
36099111 Association of Alcohol Use Disorder Risk With ADH1B, DRD2, FAAH, SLC39A8, GCKR, and PDYN Genetic Polymorphisms. Legaki E et al. 2022 In vivo (Athens, Greece)
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post774+babeb33